2 patents currently held
21 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Jun 2029. from the record
Of the 21 now held by other companies, 13 name Endoscopic Technologies LLC as their current owner, and 8 more name another party. Each row says which.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
2
Ending by 2030
Jun 2029
Next term end
1
Patent families
When these terms end
Held patents by the year their term ends
notable patents
all others
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Only 1 of the currently held patents qualifies as notable.
Formerly held, still cited
Notable
Ends Aug 2032 · High confidence
The most cited patent in this portfolio, cited by 1,094 later US patents, top 1% of utility patents granted in 2014 in our data. Protection runs to 2032.
now held by Atricure, Inc.
Also notable
Ends May 2033 · High confidence
Cited by 151 later US patents, top 5% of utility patents granted in 2016 in our data, and renewed at every maintenance window due so far. Protection runs to 2033.
now held by Atricure, Inc.
Also notable
Ends Jan 2034 · High confidence
Cited by 157 later US patents, top 5% of utility patents granted in 2015 in our data, and renewed at every maintenance window due so far. Protection runs to 2034.
now held by Atricure, Inc.
Fee deadlines
No maintenance fee falls due on this company's record before Nov 10, 2027.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
What they patent
Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.
| Pericardial Devices, Systems and Methods for Occluding an Atrial Appendage | 2 in force | to Jun 2029 |
Patents held now
Soonest term end first.
Showing 1 to 2 of 2
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,278,704 | Pericardial Devices, Systems and Methods for Occluding an Atrial Appendage In force · High confidence | In force | High confidence | |
| US 12,161,342 | Pericardial Devices, Systems and Methods for Occluding an Atrial Appendage In force · High confidence | In force | High confidence |
Also on record, not counted in the 2: 21 patents in force now held by others · 4 patents ended · 5 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
2 computed term dates come from a chain with an unresolved parent. A continuity parent has not yet been fetched from USPTO's records. The term is dated from this application's own claim; no earlier date is assumed until the parent is resolved.